| Year |
Citation |
Score |
| 2023 |
Lei B, Liu LB, Stokes L, Giangrande PH, Miller FJ, Yazdani SK. Smooth muscle cell-targeted RNA ligand promotes accelerated reendothelialization in a swine peripheral injury model. Molecular Therapy. Nucleic Acids. 34: 102023. PMID 37727270 DOI: 10.1016/j.omtn.2023.08.025 |
0.355 |
|
| 2023 |
Kolovskaya OS, Zyuzyukina AV, Dassie JP, Zamay GS, Zamay TN, Boyakova NV, Khorzhevskii VA, Kirichenko DA, Lapin IN, Shchugoreva IA, Artyushenko PV, Tomilin FN, Veprintsev DV, Glazyrin YE, Minic Z, ... ... Giangrande PH, et al. Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples. Frontiers in Molecular Biosciences. 10: 1184285. PMID 37363395 DOI: 10.3389/fmolb.2023.1184285 |
0.766 |
|
| 2023 |
Santana-Viera L, Dassie JP, Rosàs-Lapeña M, Garcia-Monclús S, Chicón-Bosch M, Pérez-Capó M, Pozo LD, Sanchez-Serra S, Almacellas-Rabaiget O, Maqueda-Marcos S, López-Alemany R, Thiel WH, Giangrande PH, Tirado OM. Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors. Molecular Therapy. Nucleic Acids. 32: 758-772. PMID 37251690 DOI: 10.1016/j.omtn.2023.05.003 |
0.773 |
|
| 2023 |
Liu W, Iwamoto N, Marappan S, Luu K, Tripathi S, Purcell-Estabrook E, Shelke JD, Shah H, Lamattina A, Pan Q, Schrand B, Favaloro F, Bedekar M, Chatterjee A, Desai J, ... ... Giangrande PH, et al. Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference. Nucleic Acids Research. PMID 37070173 DOI: 10.1093/nar/gkad268 |
0.341 |
|
| 2022 |
Yazdani SK, Lei B, Cawthon CV, Cooper K, Huett C, Giangrande PH, Miller FJ. Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease. Molecular Therapy. Nucleic Acids. 29: 577-583. PMID 36090749 DOI: 10.1016/j.omtn.2022.08.007 |
0.334 |
|
| 2021 |
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Aptamers: cutting edge of cancer therapies. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34146729 DOI: 10.1016/j.ymthe.2021.06.010 |
0.373 |
|
| 2021 |
Catuogno S, Esposito CL, Giangrande PH. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery. Methods in Molecular Biology (Clifton, N.J.). 2282: 31-42. PMID 33928568 DOI: 10.1007/978-1-0716-1298-9_3 |
0.402 |
|
| 2020 |
Ptacek J, Zhang D, Qiu L, Kruspe S, Motlova L, Kolenko P, Novakova Z, Shubham S, Havlinova B, Baranova P, Chen SJ, Zou X, Giangrande P, Barinka C. Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer. Nucleic Acids Research. PMID 32525981 DOI: 10.1093/Nar/Gkaa494 |
0.45 |
|
| 2020 |
Almacellas-Rabaiget O, Monaco P, Huertas-Martinez J, García-Monclús S, Chicón-Bosch M, Maqueda-Marcos S, Fabra-Heredia I, Herrero-Martín D, Rello-Varona S, de Alava E, López-Alemany R, Giangrande PH, Tirado OM. LOXL2 Promotes Oncogenic Progression in Alveolar Rhabdomyosarcoma Independently of its Catalytic Activity. Cancer Letters. PMID 31911079 DOI: 10.1016/J.Canlet.2019.12.040 |
0.375 |
|
| 2019 |
Veeramani S, Blackwell SE, Thiel WH, Yang ZZ, Ansell SM, Giangrande PH, Weiner GJ. An RNA aptamer-based biomarker platform demonstrates high soluble CD25 occupancy by IL2 in the serum of follicular lymphoma patients. Cancer Immunology Research. PMID 31383650 DOI: 10.1158/2326-6066.Cir-18-0821 |
0.33 |
|
| 2019 |
Udofot O, Lin LH, Thiel WH, Erwin M, Turner E, Miller FJ, Giangrande PH, Yazdani SK. Delivery of Cell-Specific Aptamers to the Arterial Wall with an Occlusion Perfusion Catheter. Molecular Therapy. Nucleic Acids. 16: 360-366. PMID 30986697 DOI: 10.1016/J.Omtn.2019.03.005 |
0.516 |
|
| 2019 |
Urak KT, Blanco GN, Shubham S, Lin LH, Dassie JP, Thiel WH, Chen Y, Sonkar VK, Lei B, Murthy S, Gutierrez WR, Wilson ME, Stiber JA, Klesney-Tait J, Dayal S, ... ... Giangrande PH, et al. RNA inhibitors of nuclear proteins responsible for multiple organ dysfunction syndrome. Nature Communications. 10: 116. PMID 30631065 DOI: 10.1038/S41467-018-08030-Y |
0.752 |
|
| 2018 |
Ruiz Ciancio D, Vargas MR, Thiel WH, Bruno MA, Giangrande PH, Mestre MB. Aptamers as Diagnostic Tools in Cancer. Pharmaceuticals (Basel, Switzerland). 11. PMID 30208607 DOI: 10.3390/Ph11030086 |
0.446 |
|
| 2018 |
Garcia-Monclús S, López-Alemany R, Almacellas-Rabaiget O, Herrero-Martín D, Huertas-Martinez J, Lagares-Te L, Alba-Pavón P, Hontecillas-Prieto L, Mora J, de Álava E, Rello-Varona S, Giangrande PH, Tirado OM. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. International Journal of Cancer. PMID 29582409 DOI: 10.1002/Ijc.31405 |
0.379 |
|
| 2017 |
Kruspe S, Dickey DD, Urak KT, Blanco GN, Miller MJ, Clark KC, Burghardt E, Gutierrez WR, Phadke SD, Kamboj S, Ginader T, Smith BJ, Grimm SK, Schappet J, Ozer H, ... ... Giangrande PH, et al. Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology. Molecular Therapy. Nucleic Acids. 8: 542-557. PMID 28918054 DOI: 10.1016/J.Omtn.2017.08.004 |
0.439 |
|
| 2017 |
Kruspe S, Giangrande PH. Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects. Biomedicines. 5. PMID 28792479 DOI: 10.3390/Biomedicines5030045 |
0.523 |
|
| 2017 |
Kruspe S, Giangrande PH. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy. Methods in Molecular Biology (Clifton, N.J.). 1632: 175-186. PMID 28730439 DOI: 10.1007/978-1-4939-7138-1_11 |
0.533 |
|
| 2017 |
Toulmé JJ, Giangrande PH, Mayer G, Suess B, Ducongé F, Sullenger B, de Franciscis V, Darfeuille F, Peyrin E. Aptamers in Bordeaux, 24-25 June 2016. Pharmaceuticals (Basel, Switzerland). 10. PMID 28117671 DOI: 10.3390/Ph10010014 |
0.374 |
|
| 2017 |
Giangrande P, Kruspe S, Dickey D, Kamboj S, Clark K, Urak K, Burghardt E, Smith B, Thomas A, McNamara J. Abstract P1-01-14: Nuclease-activated oligonucleotide probes for detection of breast cancer circulating tumor cells (CTCs): Early clinical results Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-01-14 |
0.396 |
|
| 2017 |
Veeramani S, Blackwell SE, Thiel WH, Giangrande PH, Weiner GJ. Abstract 1606: Targeting human T regulatory cells with novel Interleukin 2 alpha - IL2 complex-specific RNA aptamer Immunology. 77: 1606-1606. DOI: 10.1158/1538-7445.Am2017-1606 |
0.396 |
|
| 2016 |
Thiel WH, Esposito CL, Dickey DD, Dassie JP, Long ME, Adam J, Streeter J, Schickling B, Takapoo M, Flenker KS, Klesney-Tait J, Franciscis V, Miller FJ, Giangrande PH. Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 24: 779-787. PMID 28135581 DOI: 10.1038/mt.2015.235 |
0.787 |
|
| 2016 |
Huertas-Martínez J, Court F, Rello-Varona S, Herrero-Martín D, Almacellas-Rabaiget O, Sáinz-Jaspeado M, Garcia-Monclús S, Lagares-Tena L, Buj R, Hontecillas-Prieto L, Sastre A, Azorin D, Sanjuan X, López-Alemany R, Moran S, ... ... Giangrande PH, et al. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with Caveolin-1. Cancer Letters. PMID 27894957 DOI: 10.1016/J.Canlet.2016.11.020 |
0.309 |
|
| 2016 |
Iaboni M, Russo V, Fontanella R, Roscigno G, Fiore D, Donnarumma E, Esposito CL, Quintavalle C, Giangrande PH, de Franciscis V, Condorelli G. Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL. Molecular Therapy. Nucleic Acids. 5: e289. PMID 27111415 DOI: 10.1038/Mtna.2016.5 |
0.387 |
|
| 2016 |
Xu X, Dickey DD, Chen SJ, Giangrande PH. Structural Computational Modeling of RNA Aptamers. Methods (San Diego, Calif.). PMID 26972787 DOI: 10.1016/J.Ymeth.2016.03.004 |
0.457 |
|
| 2016 |
Urak KT, Shore S, Rockey WM, Chen SJ, McCaffrey AP, Giangrande PH. In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs. Methods (San Diego, Calif.). PMID 26972786 DOI: 10.1016/J.Ymeth.2016.03.003 |
0.472 |
|
| 2016 |
Thiel WH, Giangrande PH. AFBI assay - Aptamer Fluorescence Binding and Internalization assay for cultured adherent cells. Methods (San Diego, Calif.). PMID 26972784 DOI: 10.1016/J.Ymeth.2016.03.005 |
0.47 |
|
| 2016 |
Thiel WH, Esposito CL, Dickey DD, Dassie JP, Long ME, Adam J, Streeter J, Schickling B, Takapoo M, Flenker KS, Klesney-Tait J, de Franciscis V, Miller FJ, Giangrande PH. Smooth Muscle Cell-Targeted RNA Aptamer Inhibits Neointimal Formation. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26732878 DOI: 10.1038/Mt.2015.235 |
0.792 |
|
| 2016 |
Dickey DD, Thomas GS, Dassie JP, Giangrande PH. Method for Confirming Cytoplasmic Delivery of RNA Aptamers. Methods in Molecular Biology (Clifton, N.J.). 1364: 209-17. PMID 26472453 DOI: 10.1007/978-1-4939-3112-5_17 |
0.811 |
|
| 2016 |
Veeramani S, Blackwell SE, Thiel WH, Giangrande PH, Weiner GJ. Novel IL-2Ralpha (CD25)-Binding RNA Aptamer to Target T Regulatory Cells Blood. 128: 3697-3697. DOI: 10.1182/Blood.V128.22.3697.3697 |
0.464 |
|
| 2016 |
Dickey DD, Giangrande PH, Thiel WH. 744. Optimizing Conditions for Aptamer Folding Using a High-Throughput Aptamer Fluorescence Binding and Internalization (AFBI) Assay Molecular Therapy. 24: S293. DOI: 10.1016/S1525-0016(16)33552-3 |
0.398 |
|
| 2016 |
Dickey DD, Kruspe S, Urak KT, Thiel WH, Clark KC, Burghardt E, Dassie JP, Thomas A, McNamara JO, Giangrande PH. 263. Nuclease-Activated Oligonucleotide Probes for the Rapid and Robust Detection of Breast Cancer Circulating Tumor Cells (CTCs) Molecular Therapy. 24: S104. DOI: 10.1016/S1525-0016(16)33072-6 |
0.764 |
|
| 2015 |
Dickey DD, Giangrande PH. Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells. Methods (San Diego, Calif.). PMID 26631715 DOI: 10.1016/J.Ymeth.2015.11.020 |
0.442 |
|
| 2015 |
Condorelli G, Giangrande PH, de Franciscis V. Arresting the colonial destiny of metastatic seeds with DNA aptamers. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 982-4. PMID 26022626 DOI: 10.1038/Mt.2015.85 |
0.44 |
|
| 2015 |
Thiel WH, Thiel KW, Flenker KS, Bair T, Dupuy AJ, McNamara JO, Miller FJ, Giangrande PH. Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells. Methods in Molecular Biology (Clifton, N.J.). 1218: 187-99. PMID 25319652 DOI: 10.1007/978-1-4939-1538-5_11 |
0.55 |
|
| 2015 |
Veeramani S, Blackwell SE, Thiel WH, Giangrande PH, Weiner GJ. Abstract 5022: Generation of T regulatory-cell specific RNA aptamers Cancer Research. 75: 5022-5022. DOI: 10.1158/1538-7445.Am2015-5022 |
0.464 |
|
| 2015 |
Bair T, Miller RJ, Schappet J, Giangrande PH, Thiel WH. 67. AptmR: A High Throughput Rational Aptamer Truncation Algorithm Molecular Therapy. 23: S29. DOI: 10.1016/S1525-0016(16)33672-3 |
0.323 |
|
| 2015 |
Dickey DD, Thiel WH, Clard KC, Burghardt E, Dassie JP, McNamara II JO, Giangrande PH. 63. Rapid and Sensitive Detection of Circulating Tumor Cells with Nuclease-Activated Oligonucleotide Probes Molecular Therapy. 23: S28. DOI: 10.1016/S1525-0016(16)33668-1 |
0.764 |
|
| 2015 |
Thiel WH, Esposito CL, Dickey DD, Dassie JP, Long ME, Adam J, Streeter J, Schickling B, Takapoo M, Flenker KS, Klesney-Tait J, de Franciscis V, Miller FJ, Giangrande PH. 61. Vascular Smooth Muscle Cell RNA Aptamers for the Treatment of Cardiovascular Disease Molecular Therapy. 23: S27. DOI: 10.1016/S1525-0016(16)33666-8 |
0.778 |
|
| 2014 |
Dassie JP, Hernandez LI, Thomas GS, Long ME, Rockey WM, Howell CA, Chen Y, Hernandez FJ, Liu XY, Wilson ME, Allen LA, Vaena DA, Meyerholz DK, Giangrande PH. Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1910-22. PMID 24954476 DOI: 10.1038/Mt.2014.117 |
0.788 |
|
| 2014 |
Esposito CL, Cerchia L, Catuogno S, De Vita G, Dassie JP, Santamaria G, Swiderski P, Condorelli G, Giangrande PH, de Franciscis V. Multifunctional aptamer-miRNA conjugates for targeted cancer therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1151-63. PMID 24441398 DOI: 10.1038/Mt.2014.5 |
0.753 |
|
| 2013 |
Dassie JP, Giangrande PH. Current progress on aptamer-targeted oligonucleotide therapeutics. Therapeutic Delivery. 4: 1527-46. PMID 24304250 DOI: 10.4155/Tde.13.118 |
0.778 |
|
| 2013 |
Hernandez LI, Flenker KS, Hernandez FJ, Klingelhutz AJ, McNamara JO, Giangrande PH. Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers. Pharmaceuticals (Basel, Switzerland). 6: 295-319. PMID 23894227 DOI: 10.3390/Ph6030295 |
0.547 |
|
| 2012 |
Thiel WH, Bair T, Peek AS, Liu X, Dassie J, Stockdale KR, Behlke MA, Miller FJ, Giangrande PH. Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection. Plos One. 7: e43836. PMID 22962591 DOI: 10.1371/Journal.Pone.0043836 |
0.789 |
|
| 2012 |
Huang YZ, Hernandez FJ, Gu B, Stockdale KR, Nanapaneni K, Scheetz TE, Behlke MA, Peek AS, Bair T, Giangrande PH, McNamara JO. RNA aptamer-based functional ligands of the neurotrophin receptor, TrkB. Molecular Pharmacology. 82: 623-35. PMID 22752556 DOI: 10.1124/Mol.112.078220 |
0.409 |
|
| 2012 |
Thiel KW, Hernandez LI, Dassie JP, Thiel WH, Liu X, Stockdale KR, Rothman AM, Hernandez FJ, McNamara JO, Giangrande PH. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucleic Acids Research. 40: 6319-37. PMID 22467215 DOI: 10.1093/Nar/Gks294 |
0.808 |
|
| 2012 |
Berezhnoy A, Stewart CA, Mcnamara JO, Thiel W, Giangrande P, Trinchieri G, Gilboa E. Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1242-50. PMID 22434135 DOI: 10.1038/Mt.2012.18 |
0.313 |
|
| 2011 |
Rockey WM, Hernandez FJ, Huang SY, Cao S, Howell CA, Thomas GS, Liu XY, Lapteva N, Spencer DM, McNamara JO, Zou X, Chen SJ, Giangrande PH. Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Nucleic Acid Therapeutics. 21: 299-314. PMID 22004414 DOI: 10.1089/Nat.2011.0313 |
0.488 |
|
| 2011 |
Thiel WH, Bair T, Wyatt Thiel K, Dassie JP, Rockey WM, Howell CA, Liu XY, Dupuy AJ, Huang L, Owczarzy R, Behlke MA, McNamara JO, Giangrande PH. Nucleotide bias observed with a short SELEX RNA aptamer library. Nucleic Acid Therapeutics. 21: 253-63. PMID 21793789 DOI: 10.1089/Nat.2011.0288 |
0.771 |
|
| 2011 |
Rockey WM, Huang L, Kloepping KC, Baumhover NJ, Giangrande PH, Schultz MK. Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging. Bioorganic & Medicinal Chemistry. 19: 4080-90. PMID 21658962 DOI: 10.1016/J.Bmc.2011.05.010 |
0.462 |
|
| 2010 |
Thiel KW, Giangrande PH. Intracellular delivery of RNA-based therapeutics using aptamers. Therapeutic Delivery. 1: 849-61. PMID 21643487 DOI: 10.4155/Tde.10.61 |
0.508 |
|
| 2010 |
Pastor F, Kolonias D, Giangrande PH, Gilboa E. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature. 465: 227-30. PMID 20463739 DOI: 10.1038/Nature08999 |
0.377 |
|
| 2009 |
Dassie JP, Liu XY, Thomas GS, Whitaker RM, Thiel KW, Stockdale KR, Meyerholz DK, McCaffrey AP, McNamara JO, Giangrande PH. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nature Biotechnology. 27: 839-49. PMID 19701187 DOI: 10.1038/Nbt.1560 |
0.778 |
|
| 2009 |
Thiel KW, Giangrande PH. Therapeutic applications of DNA and RNA aptamers. Oligonucleotides. 19: 209-22. PMID 19653880 DOI: 10.1089/Oli.2009.0199 |
0.471 |
|
| 2009 |
Cerchia L, Giangrande PH, McNamara JO, de Franciscis V. Cell-specific aptamers for targeted therapies. Methods in Molecular Biology (Clifton, N.J.). 535: 59-78. PMID 19377980 DOI: 10.1007/978-1-59745-557-2_5 |
0.456 |
|
| 2008 |
Mi J, Zhang X, Rabbani ZN, Liu Y, Reddy SK, Su Z, Salahuddin FK, Viles K, Giangrande PH, Dewhirst MW, Sullenger BA, Kontos CD, Clary BM. RNA Aptamer-targeted Inhibition of NF-κB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 66-73. PMID 28192708 DOI: 10.1038/sj.mt.6300320 |
0.301 |
|
| 2008 |
Leung JY, Ehmann GL, Giangrande PH, Nevins JR. A role for Myc in facilitating transcription activation by E2F1. Oncogene. 27: 4172-9. PMID 18345030 DOI: 10.1038/Onc.2008.55 |
0.306 |
|
| 2008 |
McNamara JO, Kolonias D, Pastor F, Mittler RS, Chen L, Giangrande PH, Sullenger B, Gilboa E. Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. The Journal of Clinical Investigation. 118: 376-86. PMID 18060045 DOI: 10.1172/Jci33365 |
0.4 |
|
| 2008 |
Mi J, Zhang X, Rabbani ZN, Liu Y, Reddy SK, Su Z, Salahuddin FK, Viles K, Giangrande PH, Dewhirst MW, Sullenger BA, Kontos CD, Clary BM. RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 66-73. PMID 17912235 DOI: 10.1038/Sj.Mt.6300320 |
0.413 |
|
| 2007 |
Giangrande PH, Zhang J, Tanner A, Eckhart AD, Rempel RE, Andrechek ER, Layzer JM, Keys JR, Hagen PO, Nevins JR, Koch WJ, Sullenger BA. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. 104: 12988-93. PMID 17652516 DOI: 10.1073/Pnas.0704754104 |
0.425 |
|
| 2006 |
McNamara JO, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA, Giangrande PH. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotechnology. 24: 1005-15. PMID 16823371 DOI: 10.1038/Nbt1223 |
0.573 |
|
| 2006 |
Catron DJ, Giangrande PH, Sullenger BA. 1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53 Molecular Therapy. 13: S395. DOI: 10.1016/J.Ymthe.2006.08.1123 |
0.369 |
|
| 2006 |
Giangrande PH, McNamara JO, Andrecheck E, Gilboa E, Sullenger BA. 83. Cell_Type Specific Delivery of siRNAs with Aptamer_siRNA Chimeras Molecular Therapy. 13: S35. DOI: 10.1016/j.ymthe.2006.08.101 |
0.321 |
|
| 2005 |
Mi J, Zhang X, Giangrande PH, McNamara JO, Nimjee SM, Sarraf-Yazdi S, Sullenger BA, Clary BM. Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochemical and Biophysical Research Communications. 338: 956-63. PMID 16256939 DOI: 10.1016/J.Bbrc.2005.10.043 |
0.465 |
|
| 2005 |
Zhu W, Giangrande PH, Nevins JR. Temporal control of cell cycle gene expression mediated by E2F transcription factors. Cell Cycle (Georgetown, Tex.). 4: 633-6. PMID 15876877 DOI: 10.4161/Cc.4.5.1650 |
0.316 |
|
| 2005 |
Giangrande PH, Zhang J, Layzer J, Hagen O, Nevins JR, Sullenger BA. 377. Developing siRNAs to the E2Fs to Control Vascular Growth and Remodeling Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.380 |
0.356 |
|
| 2004 |
Giangrande PH, Zhu W, Schlisio S, Sun X, Mori S, Gaubatz S, Nevins JR. A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes & Development. 18: 2941-51. PMID 15574595 DOI: 10.1101/Gad.1239304 |
0.319 |
|
| 2003 |
Giangrande PH, Hallstrom TC, Tunyaplin C, Calame K, Nevins JR. Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Molecular and Cellular Biology. 23: 3707-20. PMID 12748276 DOI: 10.1128/Mcb.23.11.3707-3720.2003 |
0.304 |
|
| 2001 |
Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 414: 457-62. PMID 11719808 DOI: 10.1038/35106593 |
0.353 |
|
| 2000 |
Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Molecular and Cellular Biology. 20: 3102-15. PMID 10757795 DOI: 10.1128/Mcb.20.9.3102-3115.2000 |
0.313 |
|
| 1997 |
Giangrande PH, Pollio G, McDonnell DP. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor Journal of Biological Chemistry. 272: 32889-32900. PMID 9407067 DOI: 10.1074/Jbc.272.52.32889 |
0.32 |
|
| Show low-probability matches. |